Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-H Yung

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cancers|September 28, 2021
The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal MicroenvironmentRui Liang, Mingo M H Yung, Fangfang He, et al.
Integrative Cancer Therapies|October 22, 2015
Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling CascadeMingo M H Yung, Fiona A Ross, D Grahame Hardie, et al.
International Journal of Molecular Sciences|December 11, 2022
New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal MetastasesShijie Zhan, Mingo M H Yung, Michelle K Y Siu, et al.
Journal of Ovarian Research|November 19, 2025
SOAT1 in ovarian cancer cells regulates immune response mediated by CD8<sup>+</sup> T cellsJiangnan He, Michelle K Y Siu, Runying Long, et al.
Cancers|October 13, 2021
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB AxisXueyu Wang, Mingo M H Yung, Rakesh Sharma, et al.
Clinical Epigenetics|July 23, 2021
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersDavid W Chan, Wai-Yip Lam, Fushun Chen, et al.
Plos One|January 10, 2013
AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activityH T Kwan, David W Chan, Patty C H Cai, et al.
Plos One|January 4, 2013
Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsDavid W Chan, Winnie W Y Hui, Patty C H Cai, et al.
Plos One|July 20, 2016
HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary TuberculosisGrace Lui, Chun Kwok Wong, Margaret Ip, et al.
The Journal of Infectious Diseases|April 24, 2015
High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus InfectionsNelson Lee, Martin C W Chan, Grace C Y Lui, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cancers|September 28, 2021
The Stress-Inducible BCL2A1 Is Required for Ovarian Cancer Metastatic Progression in the Peritoneal MicroenvironmentRui Liang, Mingo M H Yung, Fangfang He, et al.
Integrative Cancer Therapies|October 22, 2015
Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling CascadeMingo M H Yung, Fiona A Ross, D Grahame Hardie, et al.
International Journal of Molecular Sciences|December 11, 2022
New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal MetastasesShijie Zhan, Mingo M H Yung, Michelle K Y Siu, et al.
Journal of Ovarian Research|November 19, 2025
SOAT1 in ovarian cancer cells regulates immune response mediated by CD8<sup>+</sup> T cellsJiangnan He, Michelle K Y Siu, Runying Long, et al.
Cancers|October 13, 2021
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB AxisXueyu Wang, Mingo M H Yung, Rakesh Sharma, et al.
Clinical Epigenetics|July 23, 2021
Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersDavid W Chan, Wai-Yip Lam, Fushun Chen, et al.
Plos One|January 10, 2013
AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activityH T Kwan, David W Chan, Patty C H Cai, et al.
Plos One|January 4, 2013
Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsDavid W Chan, Winnie W Y Hui, Patty C H Cai, et al.
Plos One|July 20, 2016
HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary TuberculosisGrace Lui, Chun Kwok Wong, Margaret Ip, et al.
The Journal of Infectious Diseases|April 24, 2015
High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus InfectionsNelson Lee, Martin C W Chan, Grace C Y Lui, et al.
Pageof 4